knowledge -WSS

knowledge

author：comprehensive 2025-10-02 20:47:26 - browse：6

Milken June 23 — Tina Reed, Paul Kluetz, John Oyler, and Solange Peters speak at the Milken Institute Future of Health Summit. Screen capture

The Covid-19 pandemic’s rapid spread across the world demanded a quick, collaborative response. Now, experts are asking how they can take the lessons from combating Covid-19 and apply them to diseases like cancer.

“As we look at Covid and the lessons we’re learning in the last year-and-a-half, it certainly is a lesson of successes and failures,” said John Oyler, CEO of BeiGene, in an event at the Milken Institute Future of Health Summit this week. “I strongly believe in oncology that we can and will learn from this set of experiences.”

The oncology community has already had to learn some of those lessons on the fly, as Covid-19 restrictions forced more patient care and clinical trials to be conducted remotely. Many researchers didn’t have the background or technology needed to carry out virtual assessments.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： STAT Summit: Ending the crisis of Black deaths in the U.S.

explore

WSS

An outdated Medicare rule harms dementia patients with anxiety

Results on Novartis prostate cancer therapy could expand its use

Cassava Sciences’ Alzheimer’s clinical trials should be halted

UnitedHealth, Optum discontinue NaviHealth name

Roche drug slashes death risk in early

STAT wants to know your pick for a great summer read or listen

leisure time

knowledge

entertainment

Psychedelics group wrestles with new pharma identity

Congress needs to close a vaccine

In age of alternative facts, a scholarly course on calling out crap

STAT Summit: Ending the crisis of Black deaths in the U.S.

DIEP, the 'gold standard' of breast reconstruction, is under threat

FTC loses bid to block Novant's North Carolina hospital merger

DIEP, the 'gold standard' of breast reconstruction, is under threat

Congress needs to close a vaccine

How to save PrEP access — and even expand it

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

focus

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Anthony Fauci pushes back on GOP claims during Covid hearing

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

STAT Summit: Meghan O’Rourke on making chronic illness visible

Congress needs to close a vaccine

ADCs take center stage as promising cancer treatments

entertainment

hotspot

explore

leisure time